RNS29 May 2019 10:48
Not sure what everyone was expecting this morning tbh?
A miracle RNS? Its just the 2017/18 results.
Yes a higher loss because no cash flow yet and so dependant on funding to get the compounds to market, which they are nearly there with. Salaries, well they are what they are for a PLC. Of course the costs of progressing all 4 compounds was going to increase during the period to Dec18 - no surprises there.
Remember that this is the 2017-18 results and does not reflect the end of funding 101 and 401 fully with LoI JV, plus anything that has happened in the last 6 months.
201 hasn’t quite finished CT until EOW so we wouldn’t get anything further. Q3 is when analysis starts and we may get a snippet of an interim update in next few months IMHO
401 has 2 x LOI and SEEK waiting for external funding for their portion - TBA, so again little to report as yet until firmed up.
101 sounds very encouraging lMHO.
301 results thus far justify move to P1 - good.
Talks of consolidation, going bust, running off with the IP is all hearsay and speculation IMHO.
Just sitting patiently and will be pleased to get the funding out of the way so VAL can move on and get their compounds to market and see a reversal in the SP.